141MO Pathological response and early survival data according to TNBCtype4 classifier in operable triple-negative breast cancer (TNBC) treated with neoadjuvant carboplatin and docetaxel

Autor: Echavarria Diaz-Guardamino, I., Lopez-Tarruella Cobo, S., Del Monte-Millan, M., Alvarez, E., Jerez, Y., Moreno Anton, F., García Saenz, J.Á., Massarrah, T., Ocaña, I., Cebollero, M., Ballesteros Garcia, A.I., Bohn Sarmiento, U., Gomez, H., Fuentes, H.A., Herrero Lopez, B., Gamez Casado, S., Bueno, O., Jiménez-Santos, M.J., Roche-Molina, M., Martin Jimenez, M.
Zdroj: In Annals of Oncology September 2022 33 Supplement 7:S604-S604
Databáze: ScienceDirect